Topic Review
Premature Aging in CKD
The characteristics of CKD (chronic kidney disease) are similar to those of the aging process; therefore, it has been hypothesized that CKD promotes premature aging associated with related diseases. Furthermore, chronic diseases usually observed in aging, such as CVD, inflammation, vascular calcification, mineral, and bone disorders, and chronodisruption (chronic alteration of circadian rhythms), are markedly frequent in patients with CKD.
  • 488
  • 04 Aug 2021
Topic Review
Primal Therapy
Primal therapy is a trauma-based psychotherapy created by Arthur Janov, who argues that neurosis is caused by the repressed pain of childhood trauma. Janov argues that repressed pain can be sequentially brought to conscious awareness and resolved through re-experiencing specific incidents and fully expressing the resulting pain during therapy. In therapy, the patient recalls and reenacts a particularly disturbing past experience usually occurring early in life and expresses normally repressed anger or frustration especially through spontaneous and unrestrained screams, hysteria, or violence. Primal therapy was developed as a means of eliciting the repressed pain; the term Pain is capitalized in discussions of primal therapy when referring to any repressed emotional distress and its purported long-lasting psychological effects. Janov criticizes the talking therapies as they deal primarily with the cerebral cortex and higher-reasoning areas and do not access the source of Pain within the more basic parts of the central nervous system. Primal therapy is used to re-experience childhood pain—i.e., felt rather than conceptual memories—in an attempt to resolve the pain through complete processing and integration, becoming real. An intended objective of the therapy is to lessen or eliminate the hold early trauma exerts on adult behaviour. Primal therapy became very influential during a brief period in the early 1970s, after the publication of Janov's first book, The Primal Scream. It inspired hundreds of spin-off clinics worldwide and served as an inspiration for many popular cultural icons. Singer-songwriter John Lennon, actor James Earl Jones, and pianist Roger Williams were prominent advocates of primal therapy. Primal therapy has since declined in popularity, partly because Janov had not demonstrated in research the outcomes necessary to convince research-oriented psychotherapists of its effectiveness. Proponents of the methodology continue to advocate and practice the therapy or variations of it.
  • 1.7K
  • 23 Nov 2022
Topic Review
Primary Aldosteronism
Primary aldosteronism, mainly caused by aldosterone producing adenomas or bilateral adrenal hyperplasia,  is the most common cause of endocrine hypertension. Information on the role of transcriptomics, epigenetics and metabolomics in the pathophysiology of this disease is summarized herein.
  • 555
  • 23 Dec 2021
Topic Review
Primary Localized Cutaneous Nodular Amyloidosis and Sjögren’s Syndrome
Primary localized cutaneous nodular amyloidosis (PLCNA) is a rare condition attributed to plasma cell proliferation and the deposition of immunoglobulin light chains in the skin without association with systemic amyloidosis or hematological dyscrasias. It is not uncommon for patients diagnosed with PLCNA to also suffer from other auto-immune connective tissue diseases, with Sjögren’s syndrome (SjS) showing the strongest association. 
  • 338
  • 06 May 2023
Topic Review
Primary Membranous Glomerulonephritis
The detection of phospholipase A2 receptor (PLA2R) and thrombospondin domain containing 7A THSD7A among primary membranous glomerulonephritis (MGN) patients transformed the diagnosis, treatment monitoring, and prognosis. Anti-PLA2R can be detected in 70–90% of primary MGN patients while anti-THSD7A in 2–3% of anti-PLA2R negative primary MGN patients depending on the technique used. Serum and urine samples are less invasive and non-invasive, respectively, and thus can detect the presence of anti-PLA2R and anti-THSD7A with higher sensitivity and specificity, which is significant in patient monitoring and prognosis. It is better than exposing patients to a frequent biopsy, which is an invasive procedure. Different techniques of detection of PLA2R and THSD7A in patients’ urine and sera were reviewed to provide newer and alternative techniques. We proposed the use of biomarkers (PLA2R and THSD7A) in the diagnosis, treatment decision, and follow-up of patients with primary MGN.
  • 420
  • 08 Jul 2021
Topic Review
Process Analytical Technology
Various frameworks and methods, such as quality by design (QbD), real time release test (RTRT), and continuous process verification (CPV), have been introduced to improve drug product quality in the pharmaceutical industry. The methods recognize that an appropriate combination of process controls and predefined material attributes and intermediate quality attributes (IQAs) during processing may provide greater assurance of product quality than end-product testing. The efficient analysis method to monitor the relationship between process and quality should be used. Process analytical technology (PAT) was introduced to analyze IQAs during the process of establishing regulatory specifications and facilitating continuous manufacturing improvement. Although PAT was introduced in the pharmaceutical industry in the early 21st century, new PAT tools have been introduced during the last 20 years.
  • 1.4K
  • 22 Jul 2021
Topic Review
Proprotein Convertase Subtilisin/Kexin Type 9 and Atherosclerosis
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is the last discovered member of the family of proprotein convertases (PCs), mainly synthetized in hepatic cells. This serine protease plays a pivotal role in the reduction of the number of low-density lipoprotein receptors (LDLRs) on the surface of hepatocytes, which leads to an increase in the level of cholesterol in the blood. The main anti-atherosclerotic effect of PCSK9 inhibitors results from their lipid-lowering efficiency.
  • 469
  • 01 Apr 2022
Topic Review
Proteomics, Personalized Medicine and Cancer
Cancer, a major public health issue worldwide, is the second most common cause of death. Initiatives such as the Human Genome Project (HGP) and Human Proteome Project (HPP) have greatly advanced the understanding of human health and disease, including cancer, and are supporting the current trend towards personalized/precision medicine.
  • 628
  • 01 Jun 2021
Topic Review
Proteostasis in Kidney Disease&Fibrosis
Pathological insults usually disturb the folding capacity of cellular proteins and lead to the accumulation of misfolded proteins in the endoplasmic reticulum (ER), which leads to so-called “ER stress”. Increasing evidence indicates that ER stress acts as a trigger factor for the development and progression of many kidney diseases. The unfolded protein responses (UPRs), a set of molecular signals that resume proteostasis under ER stress, are thought to restore the adaptive process in chronic kidney disease (CKD) and renal fibrosis. Furthermore, the idea of targeting UPRs for CKD treatment has been well discussed in the past decade. 
  • 416
  • 26 Sep 2021
Topic Review
PSTS-h
Primary malignant cardiac tumors are rare, with a prevalence of about 0.01% among all cancer histotypes. At least 60% of them are primary soft tissue sarcomas of the heart (pSTS-h) that represent almost 1% of all STSs. The cardiac site of origin is the best way to classify pSTS-h as it is directly linked to the surgical approach for cancer removal. Indeed, histological differentiation should integrate the classification to provide insights into prognosis and survival expectancy of the patients. The prognosis of pSTS-h is severe and mostly influenced by the primary localization of the tumor, the difficulty in achieving complete surgical and pharmacological eradication, and the aggressive biological features of malignant cells.
  • 436
  • 05 Jul 2021
  • Page
  • of
  • 48
Video Production Service